1Crouse JR 3rd. Prediclive value of carotid 2 dimensional ultrasound[J]. Am J Cardiol,2001,88(2A) :27-30.
2Mohler ER, 3rd, Peripheral arterial disease: identification and implications[J]. Arch Intern Med, 2003,163(19) : 2306- 2314.
3Yamasaki Y, Kodama M, Nishizawa H, et al. Carotid intima media thickness in Japanese typy 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease[J]. Diabetes Care,2000,23(9) : 1310-1315.
4Kallikazaros I, Tsioufis C, Sideris S,et al. Carotid artery disease as a marker for the presence of severe coronary artery disease in patients evaluated for chest pain[J]. Stroke, 1999,30(5) : 1002- 1007.
6Raman PG, Thakur BS, Mathew V. Ankle brachial index as a predictor ofgeneralized atherosclerosis [ J]. J Assoc Physicians India, 2001,49: 1074-1077.
7Sukhija R, Aronow WS, Yalamanchili K, et a[. Association o{ ankle-brachial index with severity of angiographic coronary artery disease in patients with peripheral arterial disease and coronary artery disease[J]. Cardiology, 2005,103(3) : 158- 160.
8Kotsis VT, Pitiriga VCh, Stabouli SV, et al. Carotid artery intima-media thickness could predict the presence of coronery artery lesions[J]. Am J Hypertens,2005,18(5 Pt 1) :601- 606.
3He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, et al. Major causes of death among men and women in China [ J]. N Engl J Med, 2005, 353:1124- 134.
4Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk [J]. Vasc Med, 1997, 2: 221-226.
5National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ) final report [J]. Circulation, 2002, 106:3 143-421.
6Hiatt WR. Medical treatment of peripheral arterial disease and claudication [J]. N Engl Med, 2001, 344:1 608-621.
7Halperin J, Fuster V. Meeting the challenge of peripheral arterial disease [J]. Archintern Med, 2003, 163: 877-878.
8Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results flora the National Health and Nutrition Examination Storey, 1999-2000[J]. Circulation, 2004, 110: 738-743.
9Curb JD, Masaki K, Rodriguez BL, Abbott RD, Burchfiel CM, Chen R, et al. Peripherad artery disesee and cantiovascular risk factors in the elderly: the Honolulu Heart Program [ J]. Artedoscler Thromb Vasc Biol , 1996, 16:1 495- 500.
10Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, et al. Article-ram index as a predictor of cardiovascular disease and mortality in the cardiovascular health study: the Cardiovascular Health Study Group [J]. Arterioscler Thromb Vasc Biol, 1999, 19: 538-545.
5Ishii H, Tsukada T, Yoshida M. Angiotensin Ⅱ type- Ⅰ receptor blocker, candesartan, improves brachial-ankle pulse wave velocity independent of its blood pressure lowering effects in type 2 diabetes patients[J]. Intern Med, 2008,47 (5) : 2013-2015.
6Vicente I, Lahoz C, Taboada M, et al. Prevalence of an abnormal ankle-brachial index in relation to the cardiovascular risk estimated by the Framingham function [J]. Med Clin (Barc), 2005,124(17) :641-644.
7Murabito JM, Evans JC, Larson MG, et al. The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: The Framingham study [J]. Arch Intern Med, 2003,163 (16):1939-1942.
8Ostergren J, Sleight P, Dagenais K, etal. Impact of rampril in patients with evidence of 24 clinical or subclinical peripheral arterial disease[J]. Eur Heart J, 2004,25 (1) : 17-24.
9McDremott MM, Liu K, Criqui MH, et al. Ankle-brachial index and subclinical cardiac and carotid disease: (the multi-ethnic study atherosclerosis) [J]. Am J Epidemiol, 2005, 162 (1) 33-41.
10Safar ME, Blacher J, Pannier B, et al. Central pulse pressure and mortality in end-stage renal disease [J]. Hypertension, 2002,39 (3) : 735-738.
